| ²é¿´: 466 | »Ø¸´: 0 | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
[×ÊÔ´]
Target Validation in Drug Discovery
|
||
|
Target Validation in Drug Discovery Publisher: Academic Press | ISBN: 0123693934 | edition 2006 | PDF | 296 pages | 4,57 mb This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book. http://depositfiles.com/en/files/9zc4tp3wh |
» ²ÂÄãϲ»¶
¿É¿¿ÏûÏ¢£¬8ÔÂ21ºÅ(Ã÷Ìì)·Å°ñ
ÒѾÓÐ10È˻ظ´
Ö»ÓÐÿÄêÕâÖÖʱºòÀ´¹ä¹äСľ³æ
ÒѾÓÐ20È˻ظ´
»¶Ó·¢À´filecodeµÄMz6ºóµÄ´úÂëÑéÖ¤Æä¹æÂÉ
ÒѾÓÐ125È˻ظ´
½ñÌì»ù½ð»á³ö½á¹ûÂð£¿20260819
ÒѾÓÐ15È˻ظ´
ʱ¼ä´Á±äÁË£¬ÄÜ¿´³öʲôÎÊÌ⣿
ÒѾÓÐ16È˻ظ´
filecode£¬4¸öjtjcÁË
ÒѾÓÐ13È˻ظ´
ΪʲôÓà¶î±¦µÄÄ껯ÀûÂÊÔ½À´Ô½µÍ£¿Ö÷ÒªÔÒòÓÐÄÄЩ£¿
ÒѾÓÐ5È˻ظ´
½ñÌì·Å°ñûϷÁ˰É
ÒѾÓÐ5È˻ظ´
½ñÌì·Å°ñÂð£¿
ÒѾÓÐ15È˻ظ´
filecode=ºóÃæµÚÒ»¸öÊÇ´óд×Öĸ
ÒѾÓÐ12È˻ظ´









»Ø¸´´ËÂ¥